Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma

SIMPLE SUMMARY: A majority of melanoma occurs in people over 65 years. BRAF and MEK inhibitors are standard of care for BRAF mutated metastatic melanoma. The aim of the study was to explore tolerability of targeted therapy in a cohort of patients extracted from a biobank. Patients treated by BRAF an...

Descripción completa

Detalles Bibliográficos
Autores principales: Becquart, Ondine, Oriano, Bastien, Dalle, Stéphane, Mortier, Laurent, Leccia, Marie Thérèse, Dutriaux, Caroline, Dalac, Sophie, Montaudié, Henri, De Quatrebarbes, Julie, Brunet-Possenti, Florence, Saiag, Philippe, Lesimple, Thierry, Beylot-Barry, Marie, Aubin, Francois, Stoebner, Pierre-Emmanuel, Arnault, Jean-Philippe, Dreno, Brigitte, Porcher, Raphael, Lebbe, Celeste, Guillot, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235702/
https://www.ncbi.nlm.nih.gov/pubmed/34207200
http://dx.doi.org/10.3390/cancers13123042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235702/
https://www.ncbi.nlm.nih.gov/pubmed/34207200
http://dx.doi.org/10.3390/cancers13123042

Ejemplares similares